V. H. Peña-García

Evaluating expanded age eligibility for typhoid vaccination in endemic settings: A cost-effectiveness modeling study

Expanding TCV catch-up vaccination eligibility beyond 15 years up to age 35 years provides additional public health benefit in some settings, and is cost-saving in very-high-incidence settings and in drug-resistant scenarios, and cost-effective in high-incidence settings where case fatality and costs of illness are hig...